SaMD, artificial intelligence and machine learning: regulators’ first steps

2022-09-16T16:01:49+00:00September 7th, 2022|Categories: Medical Research, Meditrial|

Dr.ssa Paola Antonini, Meditrial scientific director The International medical device regulators forum (Imdrf), describes Software as a Medical Device (SaMD) as software that can run on generic (non-medical) computing platforms. They can be used in conjunction with other [...]

SOLVING THE DATA MANAGEMENT CHALLENGE IN DIGITAL CLINICAL TRIALS

2022-08-04T13:43:59+00:00July 20th, 2022|Categories: Medical Research, Meditrial|Tags: , , , , , , , |

When novel drugs or medical devices are evaluated in clinical trials, the data generated in this process is called clinical data. Improving the use of technology in clinical trials is now a prime opportunity for the life sciences industry. [...]

CLINICAL TRIAL DESIGN: THE REVOLUTION OF NEW STATISTICAL PRINCIPLES

2022-08-04T14:05:47+00:00July 6th, 2022|Categories: Meditrial|Tags: , , , , |

Edited by Dr. Monica Tocchi, Meditrial medical director. The organization called ICH (International council for harmonization of technical requirements for pharmaceuticals for human use) is a global organization that unites regulatory authorities and the pharmaceutical industry in the common [...]

CLINICAL EVIDENCE FOR IVDs: THE NEW GOOD CLINICAL PRACTICES

2022-08-04T14:21:10+00:00June 28th, 2022|Categories: Meditrial|Tags: , , , , , , , |

Atty. Alessia Nuciari, director of compliance Meditrial. The in vitro diagnostics industry has undergone a substantial transformation. IVDR Regulation 746/2017, published in May 2017 and applied from May 26, 2022, introduced major changes in the industry. The main [...]

OBSERVATIONAL STUDIES AND REGISTRIES: REAL WORLD EVIDENCE

2022-07-05T13:38:23+00:00June 15th, 2022|Categories: Meditrial|Tags: , , , , |

Dr. Paola Antonini, Meditrial scientific director. If well designed, observational studies and registries produce treatment effect data comparable in importance to those in randomized controlled trials,[1] generating information missing in traditional interventional studies and real-world data to support marketing [...]

THE NEW ROLE OF THE PATIENT AS AN ACTIVE PLAYER IN CLINICAL TRIALS

2022-07-06T15:23:20+00:00June 8th, 2022|Categories: Meditrial|Tags: , , , , , |

Research and innovation are based on rigorous clinical trials involving patients firsthand. The main actor in clinical trials is the patient affected by the disease under examination. Including the patient’s perspective allows us to reduce barriers that otherwise limit your [...]

Go to Top